Association Between Depression Severity and Ovarian Cancer Among American Women: A Cross-Sectional Study
- PMID: 40698040
- PMCID: PMC12282544
- DOI: 10.2147/IJWH.S520260
Association Between Depression Severity and Ovarian Cancer Among American Women: A Cross-Sectional Study
Abstract
Objective: Inflammation is one of the main causes of ovarian cancer. Depression leads to an increase in pro-inflammatory cytokines, which in turn affects the progression and severity of cancer. There is a lack of research on the relationship between depression severity and ovarian cancer. This study aimed to explore the relationship between depression severity and ovarian cancer.
Methods: The study used data from seven cycles of the National Health and Nutrition Examination Survey (NHANES, 2005-2018). Weighted multivariable logistic regression models were used to analyze the association between depression severity and ovarian cancer.
Results: A total of 14,843 women without cancer and 56 women only with ovarian cancer were included in this study. Weighted multivariable logistic regression models showed that severe depression was associated with ovarian cancer (unadjusted model, OR: 4.94, 95% CI: 1.14, 21.35, p < 0.05, p for trend: 0.1; partially adjusted model, OR: 6.10, 95% CI: 1.35, 27.51, p < 0.05, p for trend: 0.04; fully adjusted model, OR: 5.82, 95% CI: 1.19, 28.52, p < 0.05, p for trend: 0.05).
Conclusion: Severe depression was positively correlated with ovarian cancer. Longitudinal studies are necessary to explore causality.
Keywords: NHANES; PHQ-9; cross-sectional study; depression severity; ovarian cancer.
© 2025 Yang et al.
Conflict of interest statement
Li Yang and Shuang Zhang are co-first authors for this study. The authors declare no competing interests in this work. The authors also confirm that there are no funding sources or affiliations that may influence the design, analysis, or interpretation of the research.
Similar articles
-
The association between hearing loss and depression in the China health and retirement longitudinal study.Sci Rep. 2025 Jul 1;15(1):20537. doi: 10.1038/s41598-025-05749-9. Sci Rep. 2025. PMID: 40595946 Free PMC article.
-
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2. Cochrane Database Syst Rev. 2022. PMID: 36161421 Free PMC article.
-
NHANES 2005-2018 data reveal high albumin-bilirubin scores are associated with depression.BMC Psychiatry. 2025 Jul 1;25(1):660. doi: 10.1186/s12888-025-07082-x. BMC Psychiatry. 2025. PMID: 40597971 Free PMC article.
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280. Health Technol Assess. 2001. PMID: 11701100
-
Ketamine and other glutamate receptor modulators for depression in bipolar disorder in adults.Cochrane Database Syst Rev. 2015 Sep 29;(9):CD011611. doi: 10.1002/14651858.CD011611.pub2. Cochrane Database Syst Rev. 2015. Update in: Cochrane Database Syst Rev. 2021 Oct 8;10:CD011611. doi: 10.1002/14651858.CD011611.pub3. PMID: 26415966 Updated.
References
-
- Ovarian Cancer Research Alliance. Statistics. Available from: https://ocrahope.org/patients/about-ovarian-cancer/statistics/. Accessed December 21, 2024.
-
- National Cancer Institute. Surveillance, epidemiology, and end results program. cancer stat facts: ovarian cancer. Available from: https://seer.cancer.gov/statfacts/html/ovary.html. Accessed December 21, 2024.
LinkOut - more resources
Full Text Sources